Advances and critical aspects in cancer treatment development using digital twins
Briefings in Bioinformatics · 01.05.2025 · 26 (3)
DOI: 10.1093/bib/bbaf237 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 02.06.2025. Verfasst von Rym Bouriga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France. Hauptthemen laut MEDLINE: Neoplasms, Artificial Intelligence, Drug Development. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Research Agency.
Abstract (Originalsprache)
The emergence of digital twins (DTs) in the arena of anticancer treatment echoes the transformative impact of artificial intelligence in drug development. DTs provide dynamic, accessible platforms that may accurately replicate patient and tumor characteristics. The potential of DTs in clinical investigation is particularly compelling. By comparing data from virtual trials with conventional trial results, medical teams can significantly enhance the reliability of their studies. Moreover, a significant breakthrough in clinical research is the ability of DT to augment patient data during ongoing trials, enabling adaptive trial designs and more robust statistical analyses to be performed even with limited patient populations. The development of DTs faces however several technical and methodological challenges. These include their tendency to produce unreliable predictions, non-factual information, reasoning errors, systematic biases, and a lack of interpretability. Future research in this field should focus on an interdisciplinary approach that brings together experts from diverse fields, including mathematicians, biologists, and physicians. This collaborative strategy promises to unlock new frontiers in personalized cancer treatment and medical methodologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
- Department of Epidemiology and Biostatistics, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
- FHU OncoAge, IHU RespirERA, IRCAN, Inserm, CNRS 7284, U1081, University Côte d'Azur, 06189 Nice, France.
- Departement of Radiotherapy, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
- Scientific Valorization, Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
Förderung
- French National Research Agency
Zitieren
APA
Bouriga, R., Bailleux, C., Gal, J., Chamorey, E., Mograbi, B., Hannoun-Levi, J. M., & Milano, G. (2025). Advances and critical aspects in cancer treatment development using digital twins. Briefings in Bioinformatics, 26(3). https://doi.org/10.1093/bib/bbaf237
Vancouver
Bouriga R, Bailleux C, Gal J, Chamorey E, Mograbi B, Hannoun-Levi JM, et al. Advances and critical aspects in cancer treatment development using digital twins. Briefings in Bioinformatics. 2025;26(3). doi:10.1093/bib/bbaf237
BibTeX
@article{Bouriga2025,
author = {Bouriga, Rym and Bailleux, Caroline and Gal, Jocelyn and Chamorey, Emmanuel and Mograbi, Baharia and Hannoun-Levi, Jean-Michel and Milano, Gerard},
title = {Advances and critical aspects in cancer treatment development using digital twins},
journal = {Briefings in Bioinformatics},
year = {2025},
volume = {26},
number = {3},
doi = {10.1093/bib/bbaf237}
}
EUVIMED